BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Press release: Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis

  December 23, 2024

   · 

  12 min read
• Press Releases

  Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

  December 23, 2024

   · 

  7 min read
• Press Releases

  OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

  December 23, 2024

   · 

  3 min read
• Press Releases

  Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

  December 23, 2024

   · 

  19 min read
• BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

  December 23, 2024

   · 

  3 min read
• Press Releases

  RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody

  December 23, 2024

   · 

  7 min read
• Press Releases

  NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape

  December 23, 2024

   · 

  11 min read
• Press Releases

  NEW CLINICAL PRACTICE GUIDELINE ON THE PROCESS FOR DIAGNOSING ALZHEIMER’S DISEASE OR A RELATED FORM OF COGNITIVE IMPAIRMENT OR DEMENTIA

  December 23, 2024

   · 

  7 min read
• Press Releases

  Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

  December 23, 2024

   · 

  5 min read
• Press Releases

  Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity

  December 23, 2024

   · 

  5 min read